The National COVID-19 Clinical Evidence Taskforce is calling for Expressions of Interest from suitably qualified individuals to join the new Infection Prevention and Control (IPC) Panel. 

The Panel is a collaboration between the Taskforce and Infection Control Expert Group (ICEG) and will be jointly Co-Chaired by one representative nominated by ICEG and one representative nominated by the Taskforce. 

The IPC Panel will aim to include broad clinical representation including (but not limited to) nursing and midwifery, allied health, medical, rural and remote, public health and Torres Strait Islander and Aboriginal people. 

Membership will include a representative with IPC experience from each of the sub-specialties listed below. 

  • IPC expert 
  • IPC expert 
  • IPC expert 
  • IPC expert 
  • Occupational and Environmental Physician 
  • Occupational hygienist 
  • Engineer (clinical) 
  • Clinician – operative/perioperative 
  • Clinician - critical care 
  • Clinician – emergency care Clinician - primary care 
  • Clinician - older people's care 
  • Clinician - women's health 
  • Clinician – paediatric and adolescent health 

 

Responsibilities 

Panel members will be required to: 

  • Participate in and contribute to the development of PICO (Population, Intervention, Comparator, Outcomes) criteria for prioritised infection prevention and control questions 
  • Review Evidence Profile tables and Summary of Findings tables for living recommendations 
  • Contribute to the development of new or revised recommendations, with evidence-based recommendations developed according to GRADE methods, and consensus-based recommendations developed according to NHMRC methods in the absence of sufficient evidence. 
  • Review curated lists of guidance sourced from clinical guidelines, position statements or protocols external to the Taskforce, and discuss the adoption or adaptation of this guidance for inclusion in the Clinical Flowcharts or other guidance. 
  • Work collaboratively with the Panel to prioritise infection prevention and control questions provided by the Guidelines Leadership Group (GLG). 
  • Participate in a weekly 1-1½ hour Panel meeting, commencing in mid-November 2020. 

 

IPC Panel Member key selection criteria 

  1. Demonstrated clinical skills and expert knowledge in infection prevention and control as it relates to their clinical specialty 
  2. Experience in, and demonstrated knowledge of, guideline development and the principles of evidence-based health care (previous experience in GRADE is desirable). 
  3. Demonstrated ability to work collaboratively with multiple and diverse groups of stakeholders to reach consensus. 
  4. Relevant and contemporary clinical experience in the Australian healthcare system from one the sub-specialty areas listed above. 

 

Candidates are invited to submit an application by COB Monday 2 November 2020 which includes: 

 

Further information about the Taskforce COI Policy.

To learn more visit the National COVID-19 Clinical Evidence Taskforce website